{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:26:30Z","timestamp":1781166390284,"version":"3.54.1"},"reference-count":23,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2025,4,28]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A critical evaluation of the US Food and Drug Administration (FDA) recommendation to avoid intracranial stent placement (ICAS) within 7\u2009days of a qualifying cerebral ischemic event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This evaluation compared the rates of 1\u2009month stroke and\/or death associated with ICAS performed within 7\u2009days and more than 7\u2009days after a qualifying cerebral ischemic event in patients with high-grade (70\u201399% in severity) intracranial stenosis in two randomized controlled trials. A logistic regression analysis was performed to identify the impact of time interval strata between the qualifying cerebral ischemic event and ICAS on 1\u2009month stroke and\/or death rate (independent ascertainment).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The rates of 1\u2009month stroke and\/or death were 14 of 112 (12.5%) and 33 of 172 (19.2%) in patients treated within 7\u2009days and more than 7\u2009days after a qualifying cerebral ischemic event, respectively (P=0.071). There was no difference in the 1\u2009month stroke and\/or death rate in patients who were treated within 7\u2009days and those treated after 7\u2009days after a qualifying cerebral ischemic event (OR 1.0004, 95% CI 0.55 to 1.84) after adjusting for age, gender, severity of stenosis strata, qualifying cerebral ischemic event type (transient ischemic attack or minor ischemic stroke), and stent used (self-expanding vs balloon expandable stents).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This analysis did not show any increased risk of 1\u2009month stroke and\/or death in patients who underwent ICAS within 7\u2009days compared with those treated more than 7\u2009days after the qualifying cerebral ischemic event. Delaying the ICAS according to current FDA recommendations may not be necessary when ICAS is indicated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2025-023318","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:10:46Z","timestamp":1749013846000},"page":"930-935","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Timing of intracranial stent placement and one month stroke and\/or death rates in patients with high-grade symptomatic intracranial stenosis: pooled analysis of SAMMPRIS and VISSIT trials"],"prefix":"10.1136","volume":"18","author":[{"given":"Adnan I","family":"Qureshi","sequence":"first","affiliation":[{"name":"Zeenat Qureshi Stroke Institute, Columbia, Missouri, USA"},{"name":"Department of Neurology, University of Missouri, Columbia, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Missouri, Columbia, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-7616","authenticated-orcid":false,"given":"Ameer E","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Valley Baptist Health System Inc, Harlingen, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-187X","authenticated-orcid":false,"given":"Nived","family":"Jayaraj Ranjini","sequence":"additional","affiliation":[{"name":"Zeenat Qureshi Stroke Institute, Columbia, Missouri, USA"},{"name":"Department of Neurology, University of Missouri, Columbia, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Fareed K","family":"Suri","sequence":"additional","affiliation":[{"name":"Zeenat Qureshi Stroke Institute, Columbia, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo R","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2026031302250908000_18.4.930.1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jon.12748","article-title":"The Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis Trial: Reanalysis Using the FDA \u201cOn Label\u201d Criteria","volume":"30","author":"Qureshi","year":"2020","journal-title":"J Neuroimaging"},{"key":"2026031302250908000_18.4.930.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105335"},{"key":"2026031302250908000_18.4.930.3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.023996"},{"key":"2026031302250908000_18.4.930.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.12000"},{"key":"2026031302250908000_18.4.930.5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamaneurol.2021.4804","article-title":"Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial","volume":"79","author":"Jia","year":"2022","journal-title":"JAMA Neurol"},{"key":"2026031302250908000_18.4.930.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.578229"},{"key":"2026031302250908000_18.4.930.7","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31821789ad"},{"key":"2026031302250908000_18.4.930.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.021"},{"key":"2026031302250908000_18.4.930.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1693"},{"key":"2026031302250908000_18.4.930.10","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.637632","article-title":"Timing and Outcomes of Intracranial Stenting in the Post-SAMMPRIS Era: A Systematic Review","volume":"12","author":"Yu","year":"2021","journal-title":"Front Neurol"},{"key":"2026031302250908000_18.4.930.11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.0000000000200030","article-title":"Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee","volume":"98","author":"Turan","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2026031302250908000_18.4.930.12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/STROKEAHA.118.023996","volume":"50","author":"Alexander","year":"2019","journal-title":"WEAVE Trial Stroke"},{"key":"2026031302250908000_18.4.930.13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012795","article-title":"Emergency Intracranial Stenting in Acute Stroke: Predictors for Poor Outcome and for Complications","volume":"9","author":"Stracke","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026031302250908000_18.4.930.14","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e318286fdc8"},{"key":"2026031302250908000_18.4.930.15","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.661173"},{"key":"2026031302250908000_18.4.930.16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(13)61088-0","article-title":"Intracranial atherosclerosis","volume":"383","author":"Qureshi","year":"2014","journal-title":"The Lancet"},{"key":"2026031302250908000_18.4.930.17","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.000590"},{"key":"2026031302250908000_18.4.930.18","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2019-015035"},{"key":"2026031302250908000_18.4.930.19","first-page":"S21","article-title":"Post hoc analysis: use and dangers in perspective","volume":"14","author":"Elliott","year":"1996","journal-title":"J Hypertens (Los Angel)"},{"key":"2026031302250908000_18.4.930.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.285063"},{"key":"2026031302250908000_18.4.930.21","doi-asserted-by":"crossref","DOI":"10.1161\/SVIN.122.000497","article-title":"A Decade On: The Evolving Renaissance in Intracranial Atherosclerotic Disease","volume":"2","author":"Beaman","year":"2022","journal-title":"SVIN"},{"key":"2026031302250908000_18.4.930.22","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002338"},{"key":"2026031302250908000_18.4.930.23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.1.50"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2025-023318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:47:27Z","timestamp":1773427647000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2025-023318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/jnis-2025-023318"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2025-023318","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}